CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind, Multicenter, Biphasic, Controlled With GARDASIL™ Dose-Escalation Study of Octavalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Adjuvanted With Amorphous Aluminum Hydroxyphosphate Sulfate (AAHS) and ISCOMATRIX™ (IMX)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00851643
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:00.543103+00:00
Published At: 2011-06-21T00:00:00+00:00
Record Updated At: 2016-02-03
Results Posted At: 2011-06-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Human Papilloma Virus", "Cervical Cancer", "Vulvar Cancer", "Vaginal Cancer", "Genital Warts"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-02-03"
protocolSection.identificationModule.nctId: "NCT00851643"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-Blind, Multicenter, Biphasic, Controlled With GARDASIL\u2122 Dose-Escalation Study of Octavalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Adjuvanted With Amorphous Aluminum Hydroxyphosphate Sulfate (AAHS) and ISCOMATRIX\u2122 (IMX)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2011-06-21"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.